{"case_name": "Upsher-Smith Laboratories, LLC v. Zydus Pharmaceuticals (USA) Inc. et al", "case_number": "21-1132", "judge": "Judge Gregory B. Williams", "date": "10-27-2022", "ocr_text": "REDACTED PUBLIC VERSIONIN THE UNITED STATES DISTRICT COURT \nFOR THE DISTRICT OF DELAWARE \nUPSHER-SMITH LABORATORIES, LLC, \nPlaintiff, \nV. \nZYDUS PHARMACEUTICALS (USA) INC. \nand CADILA HEALTHCARE LTD., \nDefendants. \nORDER \nAt Wilmington this 11th day of October 2022: Civil Action No. 21-1132-GBW \nFor the reasons set forth in the Memorandum Opinion issued this day, IT IS HEREBY \nORDERED that Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.'s \nMotion to Dismiss Plaintiff Upsher-Smith Laboratories , LLC's (\"USL\") Complaint Pursuant to \nFederal Rule of Civil Procedure 12(b)(6) (D.I. 13) is GRANTED-IN-PART and DENIED-IN\u00ad\nPART: \n1. The Motion is DENIED as to Count I; \n2. The Motion is GRANTED as to Count II and as to Count III; and \n3. Count II and Count III are dismissed with prejudice. \nBecause the Memorandum Opinion is filed under seal, the parties shall meet and confer \nand, no later than October 18, 2022, submit a joint proposed redacted version, accompanied by a \nsupporting memorandum, detailing how, under applicable law, the Court may approve any requested redactions. In the absence of a timely, compliant request, the Court will unseal the entire \nop1mon. \n2 GREGORYB. WILLIAMS \nU.S. DISTRICT JUDGE "}